Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 16, 2016 - Issue 7
Submit an article Journal homepage
733
Views
9
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment

Tessa Y.S. Le LargeDepartment of Surgery, VU University Medical Center, Amsterdam, The Netherlands;Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands;Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands
,
Mireia Mato PradoDivision of Cancer, Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine (ICTEM), Imperial College, London, UK
,
Jonathan KrellDivision of Cancer, Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine (ICTEM), Imperial College, London, UK
,
Maarten F. BijlsmaDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands
,
Laura L. MeijerDepartment of Surgery, VU University Medical Center, Amsterdam, The Netherlands
,
Geert KazemierDepartment of Surgery, VU University Medical Center, Amsterdam, The Netherlands
,
Adam E. FramptonDivision of Cancer, Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine (ICTEM), Imperial College, London, UK;HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, London, UKCorrespondence[email protected]
&
Elisa GiovannettiDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands;Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy;CNR-Nano, Institute of Nanoscience and Nanotechnology, Pisa, Italy
 show all
Pages 733-736 | Received 08 Feb 2016, Accepted 04 Apr 2016, Published online: 27 Apr 2016

References

  • Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399–405.
  • Erkan M, Adler G, Apte MV, et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61(2):172–178.
  • Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324(5933):1457–1461.
  • Rhim Andrew D, Oberstein Paul E, Thomas Dafydd H, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735–747.
  • Ozdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719–734.
  • Funel N, Giovannetti E, Pollina LE, et al. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer. Expert Rev Mol Diagn. 2011;11(7):695–701.
  • Moffitt RA, Marayati R, Flate EL, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nature Genetics. 2015;47(10):1168–1178.
  • Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature. 1999;401(6755):788–791.
  • Yang Z, Michailidis G. A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data. Bioinformatics. 2016;32(1):1–8.
  • Collisson EA, Sadanandam A, Olson P, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17(4):500–503.
  • Choi W, Porten S, Kim S, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152–165.
  • Dal Molin M, Zhang M, de Wilde RF, et al. Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis. Clin Cancer Res. 2015;21(8):1944–1950.
  • Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47–52.
  • Whatcott CJ, Diep CH, Jiang P, et al. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clin Cancer Res. 2015;21(15):3561–3568.
  • Castells M, Thibault B, Delord JP, et al. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci. 2012;13(8):9545–9571.
  • Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 2014;146(3):647–651.
  • Erkan M. The role of pancreatic stellate cells in pancreatic cancer. Pancreatology. 2013;13(2):106–109.
  • Liebl F, Demir IE, Mayer K, et al. The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Ann Surg. 2014;260(5):900–907; discussion 907–908
  • Ino Y, Yamazaki-Itoh R, Shimada K, et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 2013;108(4):914–923.
  • Mato Prado M, Frampton AE, Stebbing J, et al. Single-cell sequencing in cancer research. Expert Rev Mol Diagn. 2016;16(1):1–5.
  • Jiang J-H, Liu C, Cheng H, et al. Epithelial–mesenchymal transition in pancreatic cancer: is it a clinically significant factor? Biochimica et Biophysica Acta (BBA) Rev Cancer. 2015;1855(1):43–49.
  • Yachida S, White CM, Naito Y, et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res. 2012;18(22):6339–6347.
  • Maddipati R, Stanger BZ. Pancreatic cancer metastases harbor evidence of polyclonality. Cancer Discov. 2015;5(10):1086–1097.
  • Abel EV, Simeone DM. Biology and clinical applications of pancreatic cancer stem cells. Gastroenterology. 2013;144(6):1241–1248.
  • Cutillas PR. Role of phosphoproteomics in the development of personalized cancer therapies. Proteomics Clin Appl. 2015;9(3–4):383–395.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.